WallStreetZenWallStreetZen

NASDAQ: LRMR
Larimar Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LRMR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$36.9M
Current Profit Margin
0%

LRMR Return on Equity

Current Company
-38.8%
Current Industry
-63.5%
Current Market
188%
LRMR's Return on Equity (-38.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LRMR announces earnings.

LRMR Return on Assets

Current Company
-34.3%
Current Industry
2.9%
LRMR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LRMR Return on Capital Employed

Current Company
-42.75%
Current Industry
19.5%
LRMR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LRMR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LRMR$0.00-$36.64M-$36.95MN/AN/A
VYGR$250.01M$126.46M$132.33M+101.01%+128.28%
SLRN$0.00-$381.37M-$381.64MN/AN/A
TRDA$129.01M$14.90M-$6.69MN/AN/A
TRML$0.00-$41.97M-$42.12MN/AN/A
View Top Biotech Stocks

LRMR earnings dates

Next earnings date
May 29, 2024

Larimar Therapeutics Earnings & Revenue FAQ

What were LRMR's earnings last quarter?

On Invalid Date, Larimar Therapeutics (NASDAQ: LRMR) reported Q4 2023 earnings per share (EPS) of -$0.29, up 480% year over year. Total Larimar Therapeutics earnings for the quarter were -$12.99 million. In the same quarter last year, Larimar Therapeutics's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.

What was LRMR's earnings growth in the past year?

As of Q2 2024, Larimar Therapeutics's earnings has grown year over year. Larimar Therapeutics's earnings in the past year totalled -$36.95 million.

What is LRMR's earnings date?

Larimar Therapeutics's earnings date is Invalid Date. Add LRMR to your watchlist to be reminded of LRMR's next earnings announcement.

What was LRMR's revenue last quarter?

On Invalid Date, Larimar Therapeutics (NASDAQ: LRMR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Larimar Therapeutics's revenue was $0.00.

What was LRMR's revenue growth in the past year?

As of Q2 2024, Larimar Therapeutics's revenue has grown null year over year. Larimar Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.